FDA describes 'objectionable conditions' at New York State Psychiatric Institute

Release Date:

The facility’s institutional review board failed to report a 2021 incident and “serious and ongoing noncompliance” by a principal investigator, according to a letter released by the federal agency this week.

FDA describes 'objectionable conditions' at New York State Psychiatric Institute

Title
Racial, economic disparities skew New Jersey data on autism, intellectual disability
Copyright
Release Date

flashback